Literature DB >> 19685056

Relapsing polychondritis: new therapeutic strategies with biological agents.

Paola Sabrina Buonuomo1, Claudia Bracaglia, Andrea Campana, Maya El Hachem, Andrea Diociaiuti, Antonella Insalaco, Fabrizio De Benedetti, Beatrice Chiarini Testa, Elisabetta Cortis, Giovanni Carlo De Vincentiis, Alberto G Ugazio.   

Abstract

Relapsing polychondritis (RP) is a rare disease of unknown etiology characterized by recurrent episodes of inflammation resulting in the destruction of cartilaginous tissues. We describe a young girl with RP unresponsive to conventional therapy.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19685056     DOI： 10.1007/s00296-009-0981-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  10 in total

Review 1.  Relapsing polychondritis: a clinical review.

Authors:  Erik Letko; Panayotis Zafirakis; Stefanos Baltatzis; Adamantia Voudouri; Charalampos Livir-Rallatos; C Stephen Foster
Journal:  Semin Arthritis Rheum       Date:  2002-06       Impact factor: 5.532

2.  Sustained response to infliximab in 2 patients with refractory relapsing polychondritis.

Authors:  David Saadoun; Chantal Job Deslandre; Yannick Allanore; Xuân-Viêt Pham; Anré Kahan
Journal:  J Rheumatol       Date:  2003-06       Impact factor: 4.666

3.  Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab.

Authors:  S Mpofu; C Estrach; J Curtis; R J Moots
Journal:  Rheumatology (Oxford)       Date:  2003-09       Impact factor: 7.580

4.  Relapsing polychondritis--treatment with cyclosporin A.

Authors:  A D Ormerod; L J Clark
Journal:  Br J Dermatol       Date:  1992-09       Impact factor: 9.302

5.  Successful treatment of relapsing polychondritis with infliximab.

Authors:  C Richez; C Dumoulin; X Coutouly; T Schaeverbeke
Journal:  Clin Exp Rheumatol       Date:  2004 Sep-Oct       Impact factor: 4.473

6.  Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra).

Authors:  P Vounotrypidis; G T Sakellariou; D Zisopoulos; C Berberidis
Journal:  Rheumatology (Oxford)       Date:  2006-03-01       Impact factor: 7.580

7.  Efficacy of anakinra in a patient with refractory relapsing polychondritis.

Authors:  Daniel Wendling; Sophie Govindaraju; Clément Prati; Eric Toussirot; Ewa Bertolini
Journal:  Joint Bone Spine       Date:  2008-07-31       Impact factor: 4.929

Review 8.  Relapsing polychondritis: prospective study of 23 patients and a review of the literature.

Authors:  L P McAdam; M A O'Hanlan; R Bluestone; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1976-05       Impact factor: 1.889

9.  A case of life-threatening refractory polychondritis successfully treated with combined intensive immunosuppressive therapy with methotrexate.

Authors:  Kunihiro Yamaoka; Kazuyoshi Saito; Kentaro Hanami; Shingo Nakayamada; Masao Nawata; Shigeru Iwata; Taeko Azuma; Yoshiya Tanaka
Journal:  Mod Rheumatol       Date:  2007-04-20       Impact factor: 3.023

10.  Relapsing polychondritis. Survival and predictive role of early disease manifestations.

Authors:  C J Michet; C H McKenna; H S Luthra; W M O'Fallon
Journal:  Ann Intern Med       Date:  1986-01       Impact factor: 25.391
  10 in total
  6 in total

Review 1.  Relapsing polychondritis: a review.

Authors:  Aman Sharma; Karthik Gnanapandithan; Kusum Sharma; Susmita Sharma
Journal:  Clin Rheumatol       Date:  2013-07-26       Impact factor: 2.980

Review 2.  Relapsing polychondritis in childhood: three case reports, comparison with adulthood disease and literature review.

Authors:  Adriana R Fonseca; Sheila K F de Oliveira; Marta C F Rodrigues; Ierecê L Aymoré; Romeu C Domingues; Flavio R Sztajnbok
Journal:  Rheumatol Int       Date:  2012-01-01       Impact factor: 2.631

Review 3.  An expanding role for interleukin-1 blockade from gout to cancer.

Authors:  Charles Anthony Dinarello
Journal:  Mol Med       Date:  2014-12-16       Impact factor: 6.354

Review 4.  Treating inflammation by blocking interleukin-1 in humans.

Authors:  Charles A Dinarello; Jos W M van der Meer
Journal:  Semin Immunol       Date:  2013-11-23       Impact factor: 11.130

5.  Assessment of TNF-α inhibitors in airway involvement of relapsing polychondritis: A systematic review.

Authors:  Josette Biya; Sandra Dury; Jeanne-Marie Perotin; Claire Launois; Maxime Dewolf; Gaëtan Deslée; François Lebargy
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.889

Review 6.  Hemophagocytic Lymphohistiocytosis and Relapsing Polychondritis with Acute Myelogenous Leukemia: Case Report and Review of the Literature.

Authors:  Hamza M Alsaid; Adnan A M Wahdan; Ihab N Tahboub; Nour M Almakadma
Journal:  Am J Case Rep       Date:  2020-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.